Sensitised transplant candidates face longer waiting time, higher mortality & increased rejection. ENGAGE tackles pre and post-transplant management through well-defined humoral risk stratification & evidence-based care. See the ENGAGE II report & stay tuned to learn more about ENGAGE III.